Everand Logo

Welcome to Everand!

  • STAT

    It’s a big week for debates about drug prices, whether pharma likes it or not

    An insider's guide to the politics and policy of health care.
    by Nicholas Florko and Lev Facher Jun 25, 2019 3 minutes

    D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

    Choose your fighter: The Democratic debates are a chance for candidates to flash their policy chops

    This week’s Democratic primary debates (two 10-candidate panels, each at 9 p.m. on MSNBC this Wednesday and Thursday) are likely to spotlight health care issues ranging from “Medicare for All” to drug pricing to addiction treatment, after months of those issues playing a central role at campaign rallies and town halls.

    Already, Joe Biden to “cure cancer” as president. Sen. Kamala

    You’re reading a preview, subscribe to read more.

    More from STAT

    STAT2 min read
    STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
    A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
    STAT1 min read
    USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
    With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
    STAT1 min read
    Opinion: STAT+: How AI Can Help Satisfy FDA’s Drug, Device Diversity Requirements
    To meet the Food and Drug Omnibus Reform Act, companies must rethink their current clinical trial strategies. Including AI and machine learning approaches can help.

    Related Books & Audiobooks